One of the main challenges in fibrosis detection is the lack of highly sensitive and specific biomarkers that can reliably indicate early-stage fibrosis. Additionally, the invasiveness of traditional methods like biopsy limits their use. Non-invasive imaging and serological markers are under continuous development to overcome these limitations.
